Net profit of Concord Drugs rose 375.00% to Rs 0.19 crore in the quarter ended September 2025 as against Rs 0.04 crore during the previous quarter ended September 2024. Sales declined 16.83% to Rs 10.28 crore in the quarter ended September 2025 as against Rs 12.36 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales10.2812.36 -17 OPM %10.707.12 - PBDT0.610.41 49 PBT0.270.07 286 NP0.190.04 375 Powered by Capital Market - Live News

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Concord Drugs announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live News

Net profit of Concord Drugs rose 300.00% to Rs 0.12 crore in the quarter ended June 2025 as against Rs 0.03 crore during the previous quarter ended June 2024. Sales rose 16.42% to Rs 13.61 crore in the quarter ended June 2025 as against Rs 11.69 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales13.6111.69 16 OPM %7.497.10 - PBDT0.530.38 39 PBT0.160.04 300 NP0.120.03 300 Powered by Capital Market - Live News

Concord Drugs will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live News